BMEA Biomea Fusion
Biomea Fusion earnings company data as of 4:45 AM ET 11/1
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 3 Nov | EPS | -0.22 | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by BMEA's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $197K bought by 2 insiders
- None no sales outside a trading plan
- None no planned (10b5-1) sales
-
Rainer M Erdtmann See RemarksBuy$43K 30,000 shares at $1.43 +4.3% to stakeTraded Dec 11, 2025 Filed Dec 15, 2025
-
Michael J.m. Hitchcock CEOBuy$99K 100,000 shares at $0.9900 +667% to stakeTraded Dec 2, 2025 Filed Dec 4, 2025
-
Rainer M Erdtmann See RemarksBuy$55K 50,000 shares at $1.09 +7.8% to stakeTraded Nov 28, 2025–Dec 1, 2025 Filed Dec 2, 2025
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 8.01 | Filing Doc | |
| 8-K | 9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| DEF 14A | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| 8-K | 7.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B5 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.